SURGERY PARTNERS INC
SGRYNASDAQ🏆 #1626 by market capEarnings Nov 10 · PreUS Equity
$23.24▼ $0.12 (−0.51%)
🌅 Pre-market$23.23▼ 0.04%Regular close · extended-hours price shownTrack SGRY
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$3.04B
Small Cap
📈Revenue Growth (YoY)
-21.4%
Declining
📊Gross Margin
24.9%
Moderate
💵FCF Margin
7.5%
Moderate
⚖️P/S Ratio
1.2x
Cheap
Otter Score
64
Fair
SURGERY PARTNERS INC
SGRYAnalyst Ratings
Price
$23.24
Total
23
Raised
3
Lowered
4
Avg PT
$21.33
H / L
$24 / $17
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
StoneX | Downgraded | Buy → Hold | 2026-10-27 | — | — |
RBC Capital | Reiterated | Outperform | 2026-09-30 | $23.50 | +1.10% |
TD Cowen | Reiterated | Buy | 2026-09-18 | — | — |
JP Morgan | Reiterated | Neutral | 2026-09-14 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-11 | — | — |
Mizuho | Reiterated | Outperform | 2026-03-05 | — | — |
UBS | Reiterated | Buy | 2026-03-05 | $38.00 | +63.50% |
Barclays | Reiterated | Equal Weight | 2026-03-03 | $18.00 | −22.50% |
Benchmark | Reiterated | Buy | 2025-11-11 | — | — |
Macquarie | Reiterated | Outperform | 2025-03-11 | $31.00 | +33.40% |
Citigroup | Reiterated | Buy | 2024-08-07 | $64.00 | +175.40% |
B of A Securities | Upgraded | Neutral → Buy | 2023-06-02 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-11-22 | — | — |
Stifel | Upgraded | Hold → Buy | 2021-11-29 | — | — |
Cowen & Co. | Reiterated | Market Perform → Perform | 2021-09-10 | — | — |
Bank of America | Reiterated | Buy | 2019-11-20 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-08-07 | — | — |
Stifel Nicolaus | Upgraded | Sell → Hold | 2018-06-28 | — | — |
Jefferies | Reiterated | Buy | 2017-11-01 | $17.00 | −26.90% |
KeyBanc | Downgraded | Overweight → Sector Weight | 2017-08-09 | — | — |
Keybanc | Downgraded | Overweight → Sector Weight | 2017-08-09 | — | — |
Raymond James | Downgraded | Strong Buy → Market Perform | 2017-08-09 | $23.50 | +1.10% |
Goldman Sachs | Reiterated | Neutral | 2015-10-26 | — | — |
Institution
StoneX
Downgraded · Buy → Hold · 2026-10-27
—
—
RBC Capital
Reiterated · Outperform · 2026-09-30
$23.50
+1.10%
TD Cowen
Reiterated · Buy · 2026-09-18
—
—
JP Morgan
Reiterated · Neutral · 2026-09-14
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-11
—
—
Mizuho
Reiterated · Outperform · 2026-03-05
—
—
UBS
Reiterated · Buy · 2026-03-05
$38.00
+63.50%
Barclays
Reiterated · Equal Weight · 2026-03-03
$18.00
−22.50%
Benchmark
Reiterated · Buy · 2025-11-11
—
—
Macquarie
Reiterated · Outperform · 2025-03-11
$31.00
+33.40%
Citigroup
Reiterated · Buy · 2024-08-07
$64.00
+175.40%
B of A Securities
Upgraded · Neutral → Buy · 2023-06-02
—
—
SVB Leerink
Reiterated · Outperform · 2022-11-22
—
—
Stifel
Upgraded · Hold → Buy · 2021-11-29
—
—
Cowen & Co.
Reiterated · Market Perform → Perform · 2021-09-10
—
—
Bank of America
Reiterated · Buy · 2019-11-20
—
—
Leerink Swann
Reiterated · Outperform · 2018-08-07
—
—
Stifel Nicolaus
Upgraded · Sell → Hold · 2018-06-28
—
—
Jefferies
Reiterated · Buy · 2017-11-01
$17.00
−26.90%
KeyBanc
Downgraded · Overweight → Sector Weight · 2017-08-09
—
—
Keybanc
Downgraded · Overweight → Sector Weight · 2017-08-09
—
—
Raymond James
Downgraded · Strong Buy → Market Perform · 2017-08-09
$23.50
+1.10%
Goldman Sachs
Reiterated · Neutral · 2015-10-26
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space